These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Clinical effects of a combination treatment with fosfomycin and clavulanic acid/ticarcillin for infections in patients complicated with hematological disorders]. Hirakawa K, Tsuda S, Misawa S, Ueda Y, Kaneko H, Nakao M, Ariyama Y, Nakai H, Seriu T, Takashima T. Jpn J Antibiot; 1994 May; 47(5):521-9. PubMed ID: 8051794 [Abstract] [Full Text] [Related]
3. [Clinical effects of cefodizime in severe infections complicated with hematological diseases. Hanshin Infection Study Group]. Teshima H, Masaoka T, Hiraoka A, Horiuchi A, Hasegawa H, Kitani T, Tagawa S, Yonezawa T, Kanayama Y, Take H. Jpn J Antibiot; 1992 Oct; 45(10):1295-304. PubMed ID: 1479681 [Abstract] [Full Text] [Related]
4. [Clinical evaluation of a combination treatment with cefminox and fosfomycin for infections complicated in patients with hematological disorders]. Seriu T, Tsuda S, Nakai H, Murakami T, Takashima T, Takahashi Y, Tanaka S, Nakagawa H, Nishigaki H, Yokota S. Jpn J Antibiot; 1991 Nov; 44(11):1197-205. PubMed ID: 1784070 [Abstract] [Full Text] [Related]
5. [Clinical evaluation of a combination therapy using cefmenoxime and cefsulodin on infections complicated by hematological disorders. Tohkai Research Group on Infections in Hematopoietic Disorders]. Minami N, Uno N, Shirakawa S, Ohno R, Okumura M, Yamamoto M, Mitomo Y, Hirano M, Shimizu S, Yamada K. Jpn J Antibiot; 1986 Mar; 39(3):713-20. PubMed ID: 3488423 [Abstract] [Full Text] [Related]
6. [A combined sulbactam/cefoperazone and amikacin therapy for the treatment of infections complicated with hematological diseases]. Takashima T, Tsuda S, Misawa S, Horiike S, Kuzuyama Y, Hirakawa K, Nakai H, Seriu T, Tanaka S, Nishida K. Jpn J Antibiot; 1993 Mar; 46(3):251-8. PubMed ID: 8510322 [Abstract] [Full Text] [Related]
9. [Therapeutic effects of a combination treatment with flomoxef and tobramycin against infections complicated with hematological disorders]. Yamane T, Tanaka K, Hasuike T, Hirai M, Misu K, Ota K, Ohira H, Nakao Y, Yasui Y, Inoue T. Jpn J Antibiot; 1992 Aug; 45(8):1050-9. PubMed ID: 1433894 [Abstract] [Full Text] [Related]
10. [Effect of combination therapy with sulbactam/cefoperazone and amikacin in the treatment of infectious diseases accompanied by hematological disorders]. Matsushima T, Tamura K, Okamoto K, Kawada E, Murayama K, Maehara T, Sadakata H, Tamura J, Sawamura M, Morita K. Jpn J Antibiot; 1993 Aug; 46(8):697-705. PubMed ID: 8230737 [Abstract] [Full Text] [Related]
13. [Clinical evaluation of panipenem/betamipron in severe infections complicating hematological disorders]. Kishida T, Sannomiya Y, Nakao Y, Yasui Y, Ota K, Ohira H, Inoue T, Furukawa Y, Yamane T, Keunsik P. Jpn J Antibiot; 1992 Feb; 45(2):172-80. PubMed ID: 1613970 [Abstract] [Full Text] [Related]
14. [Therapeutic evaluation of imipenem/cilastatin sodium for bacterial infections in patients with hematological diseases]. Sawae Y, Niho Y, Harada M, Shibuya T, Okamura T, Asano Y, Taniguchi S, Murakawa M, Toyoshima T, Kozuru M. Jpn J Antibiot; 1992 Feb; 45(2):123-35. PubMed ID: 1613965 [Abstract] [Full Text] [Related]
18. [Clinical evaluation of combination therapy with cefpirome and amikacin for infections associated with hematological disorders]. Fukuda M, Kobayashi Y, Endo K, Kawai N, Tominaga K, Bessho M, Hirashima K. Jpn J Antibiot; 1998 Apr; 51(4):298-304. PubMed ID: 9644603 [Abstract] [Full Text] [Related]